Limelight Bio Competitors and Similar CompaniesClear all
Limelight Bio's competitors and similar companies include Lexicon Pharmaceuticals, CRISPR Therapeutics, Intellia Therapeutics and Omega Therapeutics.
 Limelight Bio Limelight Bio is a multi-platform, multi-disease biopharmaceutical company developing novel gene therapies. |  Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. |  CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases. |  Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry. | ||
Founding Date | Founding Date 2016 | Founding Date 1995 | Founding Date 2013 | Founding Date 2014 | Founding Date 2017 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Philadelphia, US HQ Cambridge, US | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US | Locations Cambridge, US HQ | Locations Cambridge, US HQ |
Employees | Employees 14 | Employees 20216% increase | Employees 393 | Employees 40323% decrease | Employees 60 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 737.4 m | Valuation ($) 4.2 b | Valuation ($) 1.7 b | Valuation ($) 68.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) $67.7m (FY, 2025) | Revenue (est.) $3.1m (FY, 2023) |
Net income | Net income N/A | Net income ($50.3m) (FY, 2025) | Net income ($581.6m) (FY, 2025) | Net income ($412.7m) (FY, 2025) | Net income ($97.4m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 75m | Total funding raised $ 244.7m | Total funding raised $ 127m | Total funding raised N/A | Total funding raised $ 211m |
For sources of this data, please see the company profile
View Company Profiles
Lexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View companyCRISPR Therapeutics
HQ
Zug, CH
Employees
393
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
View companyIntellia Therapeutics
HQ
Cambridge, US
Employees
403↓ 23% decrease
Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.
View company
Omega Therapeutics
HQ
Cambridge, US
Employees
60
Omega Therapeutics is an epigenomic medicine company.
View company